From October 1, 2023 to December 31, 2023, the company has repurchased 3,762,100 shares, representing 1.03% for ¥5,053.95 million. With this, the company has completed the repurchase of 12,571,400 shares, representing 3.38% for ¥16,178.35 million under the buyback announced on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,639 JPY | -0.27% | +3.05% | +16.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.65% | 3.78B | |
+42.21% | 748B | |
+34.11% | 598B | |
-6.52% | 356B | |
+18.13% | 325B | |
+4.28% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.14% | 166B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.